| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.43▲ | 1.43▲ | 1.43▲ | 1.47▼ | 1.42▲ |
| MA10 | 1.43▲ | 1.43▲ | 1.43▲ | 1.43▼ | 1.43▼ |
| MA20 | 1.43▲ | 1.45▼ | 1.47▼ | 1.43▲ | 1.47▼ |
| MA50 | 1.47▼ | 1.48▼ | 1.43▲ | 1.43▼ | 1.40▲ |
| MA100 | 1.49▼ | 1.44▼ | 1.43▲ | 1.48▼ | 1.46▼ |
| MA200 | 1.44▼ | 1.43▲ | 1.43▲ | 1.38▲ | 1.56▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.001▼ | -0.008▼ | 0.006▲ | -0.010▼ |
| RSI | 47.334▼ | 44.815▼ | 46.338▼ | 49.043▼ | 49.121▼ |
| STOCH | 25.000 | 56.389 | 32.607 | 57.188 | 29.634 |
| WILL %R | 0.000▲ | -53.333 | -73.077 | -60.061 | -73.102 |
| CCI | 171.111▲ | 21.346 | -35.383 | -2.513 | -17.007 |
|
Wednesday, October 22, 2025 09:15 AM
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
|
|
Wednesday, October 22, 2025 04:44 AM
NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in cell culture ...
|
|
Monday, October 20, 2025 04:46 AM
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in a humanized ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/10/25 | 1.43 | 1.44 | 1.42 | 1.4318 | 99,746 |
| 22/10/25 | 1.48 | 1.50 | 1.40 | 1.44 | 473,871 |
| 21/10/25 | 1.52 | 1.52 | 1.43 | 1.48 | 269,407 |
| 20/10/25 | 1.54 | 1.57 | 1.45 | 1.52 | 550,799 |
| 17/10/25 | 1.47 | 1.63 | 1.45 | 1.50 | 581,409 |
| 16/10/25 | 1.48 | 1.49 | 1.40 | 1.45 | 248,800 |
| 15/10/25 | 1.34 | 1.455 | 1.32 | 1.44 | 275,320 |
| 14/10/25 | 1.33 | 1.35 | 1.30 | 1.35 | 135,170 |
| 13/10/25 | 1.38 | 1.39 | 1.35 | 1.36 | 114,446 |
| 10/10/25 | 1.42 | 1.425 | 1.37 | 1.37 | 97,073 |
|
|
||||
|
|
||||
|
|